News Conference News AHA 2018 Complications Following TAVR Are Going Down, US Data Show Yael L. Maxwell November 20, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
Presentation AHA 2018 REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial Presenter: Deepak L Bhatt November 16, 2018
Presentation AHA 2018 High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT) Presenter: Gregory Piazza November 11, 2018